EC Seeks Industry Feedback to Shape Serialization Policy

Posted 24 November 2011 | By

The European Commission (EC) is seeking industry comments before implementing the serialization aspect of the falsified medicines directive.  Adoption of the falsified medicines directive will make the use of unique identifiers to verify the authenticity of individual drug packages mandatory.  However, the details are still to be decided and the EC is requesting input from industry prior to making its decision.  It is hoped that the EC's harmonization of the unique identifiers will lead to the smoother implementation of the serialization process. (In-Pharma Technologist)


Categories:

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe